# OnKure Therapeutics, Inc.: Form DEF 14A, filed Apr 16, 2025

- Company: [OnKure Therapeutics, Inc.](/companies/okur.md) (CIK 1637715)
- Form: DEF 14A
- Filed: 2025-04-16
- Accepted by EDGAR: Apr 16, 2025, 16:23 ET
- Period: 2025-05-27
- Accession: 0001140361-25-014183
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1637715/000114036125014183/ny20043636x1_def14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1637715/000114036125014183/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1637715/000114036125014183/ny20043636x1_def14a.htm

Filed Apr 16, 2025.
Source: SEC EDGAR, the filing index for accession 0001140361-25-014183. Last ingested by Listed: Nov 4, 2026, 17:06 ET. No prices; not investment advice.